{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:47:57Z","timestamp":1795074477407,"version":"4.10.2"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Infections caused by\n                      <jats:italic>Enterobacteriaceae<\/jats:italic>\n                      are mainly treated with the \u03b2-lactam antibiotics, nevertheless, the emergence of species with plasmid-borne \u03b2-lactamases has decreased the efficacy of these antibiotics. Therefore, continuing studies on the resistance pattern of different regions is important for assessment of proper antimicrobial therapy protocols. The study aimed to characterize extended-spectrum \u03b2-lactamase (ESBL) and AmpC \u03b2 \u2013lactamase (AmpC) producing\n                      <jats:italic>Enterobacteriaceae<\/jats:italic>\n                      isolated from community-acquired UTIs in Egypt.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Out of 705 urine samples, 440\n                      <jats:italic>Enterobacteriaceae<\/jats:italic>\n                      isolates were investigated to detect ESBL and AmpC \u03b2 -lactamases producers by phenotypic and molecular methods.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 440\n                      <jats:italic>Enterobacteriaceae<\/jats:italic>\n                      isolates, 311 were identified as ESBL producers by phenotypic testing. ESBL genes were detected in 308 isolates.\n                      <jats:italic>BlaCTX-M-type<\/jats:italic>\n                      was the most prevalent 254 (81.6%), out of them\n                      <jats:italic>blaCTXM-15<\/jats:italic>\n                      was the commonest (152, 48.8%) followed by\n                      <jats:italic>blaCTX-M-1<\/jats:italic>\n                      (140, 45%),\n                      <jats:italic>blaCTX-M-8<\/jats:italic>\n                      (72, 23.1%) and lastly\n                      <jats:italic>blaCTX-M-2<\/jats:italic>\n                      (4, 1.3%).\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:italic>blaTEM<\/jats:italic>\n                      gene also was detected in a high rate (189, 60.7%). Two hundred and thirty-five (75.5%) of ESBL producers harbored\n                      <jats:italic>blaCTX-M<\/jats:italic>\n                      in combination with\n                      <jats:italic>blaTEM<\/jats:italic>\n                      and\/or\n                      <jats:italic>blaSHV<\/jats:italic>\n                      genes. Multiple drug resistance in the ESBL-producers was significantly (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) higher than in non\u2013ESBL producers. Imipenem was the most effective drug against ESBL producers. Among 35 cefoxitin resistant isolates, 18 (51.4%) identified as carrying AmpC genes by multiplex PCR. Within AmpC \u03b2\n                      <jats:italic>-<\/jats:italic>\n                      lactamase genes, DHA gene was the predominant gene (15, 42.3%). CIT and MOX genes were also present, but in a low rate (5, 14.2% and 4, 11.4%) respectively. Co-existence of multiple AmpC genes was detected exclusively in\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      isolates.\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolates harbored DHA gene only\n                      <jats:italic>.<\/jats:italic>\n                      However, FOX gene was not detected in the study isolates. Seventeen of isolates carrying AmpC genes were also positive for ESBL genes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The study shows that the prevalence of ESBL producing\n                      <jats:italic>Enterobacteriaceae<\/jats:italic>\n                      spread in south Egypt is alarming, however AmpC \u03b2 -lactamase production is not so high.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-020-00856-w","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T06:03:40Z","timestamp":1607580220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Prevalence and molecular characteristics of ESBL and AmpC \u03b2 -lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt"],"prefix":"10.1186","volume":"9","author":[{"given":"Ebtisam S.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4481-8608","authenticated-orcid":false,"given":"Rasha M. M.","family":"Khairy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha S.","family":"Abdelrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,10]]},"reference":[{"issue":"5","key":"856_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269\u201384.","journal-title":"Nat Rev Microbiol"},{"key":"856_CR2","first-page":"24555","volume":"4","author":"A Brolund","year":"2014","unstructured":"Brolund A. Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective. Infect Ecol Epidemiol. 2014;4:24555.","journal-title":"Infect Ecol Epidemiol"},{"key":"856_CR3","first-page":"2015","volume-title":"Antimicrobial resistance surveillance in Europe 2014. Annual report of the European antimicrobial resistance surveillance network (EARSNet)","author":"European Centre for Disease Prevention and Control","year":"2014","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2014. Annual report of the European antimicrobial resistance surveillance network (EARSNet). Stockholm: ECDC; 2014. p. 2015."},{"issue":"13","key":"856_CR4","doi-asserted-by":"publisher","first-page":"4846159","DOI":"10.1155\/2018\/4846159","volume":"2018","author":"M Abayneh","year":"2018","unstructured":"Abayneh M, Tesfaw G, Abdissa A. Isolation of Extended-Spectrum \u03b2-lactamase- (ESBL-) Producing Escherichia coli and Klebsiella pneumoniae from Patients with Community-Onset Urinary Tract Infections in Jimma University Specialized Hospital, Southwest Ethiopia. Can J Infect Dis Med Microbiol. 2018;2018(13):4846159. https:\/\/doi.org\/10.1155\/2018\/4846159 eCollection 2018.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"856_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1155\/2018\/3747521","volume":"2018","author":"KJ Walker","year":"2018","unstructured":"Walker KJ, Lee YR, Klar AR. Clinical Outcomes of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Infections with Susceptibilities among Levofloxacin, Cefepime, and Carbapenems. Can J Infect Dis Med Microbiol. 2018;2018, Article ID 3747521:6. https:\/\/doi.org\/10.1155\/2018\/3747521.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"4","key":"856_CR6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","volume":"14","author":"PA Bradford","year":"2001","unstructured":"Bradford PA. Extended-spectrum beta-lactamases in the 21 st century: characterization, epidemiology, and detection of this important resistance threat. J Clin Microbiol Rev. 2001;14(4):933\u201351.","journal-title":"J Clin Microbiol Rev"},{"issue":"3","key":"856_CR7","first-page":"207","volume":"2","author":"S Thenmozhi","year":"2014","unstructured":"Thenmozhi S, Moorthy K, Sureshkumar B, Suresh M. Antibiotic resistance mechanism of ESBL producing Enterobacteriaceae in clinical field: a review. Int J Pure Appl Biosci. 2014;2(3):207\u201326.","journal-title":"Int J Pure Appl Biosci"},{"key":"856_CR8","first-page":"11","volume":"17","author":"S Ghafourian","year":"2015","unstructured":"Ghafourian S, Sadeghifard N, Soheili S, Sekawi Z. Extended spectrum beta-lactamases: definition, classification and epidemiology. Curr Issues Mol Biol. 2015;17:11\u201321.7.","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"856_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/1040841X.2012.691460","volume":"39","author":"WH Zhao","year":"2013","unstructured":"Zhao WH, Hu ZQ. Epidemiology and genetics of CTX-M extended-spectrum\u03b2-lactamases in gram-negative bacteria. Crit Rev Microbiol. 2013;39(1):79\u201310.","journal-title":"Crit Rev Microbiol"},{"key":"856_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1128\/CMR.00036-08","volume":"22","author":"G Jacoby","year":"2009","unstructured":"Jacoby G. AmpC-lactamases. Clin Microbiol Rev. 2009;22:161\u201382.","journal-title":"Clin Microbiol Rev"},{"key":"856_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1128\/AAC.00862-08","volume":"53","author":"T Tan","year":"2009","unstructured":"Tan T, Ng S, Teo L, Koh Y, Teok C. Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Antimicrob Agents Chemother. 2009;53:146\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"856_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mjafi.2012.02.001","volume":"69","author":"N Grover","year":"2013","unstructured":"Grover N, Sahni AK, Bhattacharya S. Therapeutic challenges of ESBLS and AmpC beta-lactamase producers in a tertiary care center. Med J Armed Forces India. 2013;69:4\u201310.","journal-title":"Med J Armed Forces India"},{"key":"856_CR13","volume-title":"Antimicrobial resistance in developing countries","author":"DK Byarugaba","year":"2009","unstructured":"Byarugaba DK. Antimicrobial resistance in developing countries. New York: Springer; 2009."},{"key":"856_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2307\/2091346","volume":"30","author":"L Kish","year":"1965","unstructured":"Kish L. Sampling organizations and groups of unequal sizes. Am Sociol Rev. 1965;30:564\u201372.","journal-title":"Am Sociol Rev"},{"issue":"1","key":"856_CR15","doi-asserted-by":"publisher","first-page":"e8556","DOI":"10.5812\/jjm.8556","volume":"7","author":"M Wassef","year":"2014","unstructured":"Wassef M, Behiry I, Younan M, El Guindy N, Mostafa S, Abada E. Genotypic identification of AmpC \u03b2-lactamases production in gram-negative bacilli isolates. Jundishapur J Microbiol. 2014;7(1):e8556.","journal-title":"Jundishapur J Microbiol"},{"key":"856_CR16","first-page":"1","volume":"26","author":"CLSI. Clinical and laboratory standards institute","year":"2016","unstructured":"CLSI. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing. M100S. 2016;26:1\u2013129.","journal-title":"M100S"},{"key":"856_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201378.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"856_CR18","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1128\/AAC.35.9.1697","volume":"35","author":"GA Jacoby","year":"1991","unstructured":"Jacoby GA, Medeiros AA. More extended Spectrum beta lactamases. Antimicrob Agents Chemother. 1991;35(9):1697\u2013704.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"856_CR19","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1128\/JCM.00404-11","volume":"49","author":"S Polsfuss","year":"2011","unstructured":"Polsfuss S, Bloemberg GV, Giger J, Meyer V, Bottger EC, Hombach M. Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae. J Clin Microbiol. 2011;49(8):2798\u2013803.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"856_CR20","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1128\/JCM.43.12.5945-5949.2005","volume":"43","author":"WM Dunne Jr","year":"2005","unstructured":"Dunne WM Jr, Hardin DJ. Use of several inducer and substrate antibiotic combinations in a disk approximation assay format to screen for AmpC induction in patient isolates of Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia spp. J Clin Microbiol. 2005;43(12):5945\u20139.","journal-title":"J Clin Microbiol"},{"key":"856_CR21","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1128\/AAC.47.11.3554-3560.2003","volume":"47","author":"DL Paterson","year":"2003","unstructured":"Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, Rice LB, Bonomo RA. Extended-spectrum \u03b2-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type \u03b2-lactamases. Antimicrob Agents Chemother. 2003;47:3554\u201360.","journal-title":"Antimicrob Agents Chemother"},{"key":"856_CR22","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1128\/AAC.48.4.1249-1255.2004","volume":"48","author":"C Eckert","year":"2004","unstructured":"Eckert C, Gautier V, Saladin-Allard M, et al. Dissemination of CTX-M-type \u03b2-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother. 2004;48:1249\u201355.","journal-title":"Antimicrob Agents Chemother"},{"key":"856_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/jac\/dki412","volume":"57","author":"N Woodford","year":"2006","unstructured":"Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum b-lactamases. J Antimicrob Chemother. 2006;57:154\u20135.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"856_CR24","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/jac\/dkn109","volume":"61","author":"DY Muzaheed","year":"2008","unstructured":"Muzaheed DY, Adams-Haduch JM, Endimiani A, Sidjabat HE, Gaddad SM, Paterson DL. High prevalence of CTX-M-15\u2013producing Klebsiella pneumoniae among inpatients and outpatients with urinary tract infection in southern India. J Antimicrob Chemother. 2008;61(6):1393\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"856_CR25","doi-asserted-by":"crossref","unstructured":"Pe\u2019rez-Pe\u2019rez FJ, and Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40:2153\u20132162.","DOI":"10.1128\/JCM.40.6.2153-2162.2002"},{"key":"856_CR26","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1128\/AAC.00915-06","volume":"50","author":"CH Park","year":"2006","unstructured":"Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6_)-Ib-cr encoding a ciprofloxacin modifying enzyme. Antimicrob Agents Chemother. 2006;50:3953\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"856_CR27","unstructured":"World Health Organization. Antimicrobial resistance: global report on surveillance: WHO; 2014. http:\/\/www.who.int\/drugresistance\/documents\/surveillancereport\/en\/. Accessed 17 May 2018."},{"key":"856_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/mdr.2010.0063","volume":"17","author":"N Fam","year":"2011","unstructured":"Fam N, Leflon-Guibout V, Fouad S, Aboul-Fadl L, Marcon E, Desouky D, et al. CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. Microb Drug Resist. 2011;17:67\u201373.","journal-title":"Microb Drug Resist"},{"issue":"1","key":"856_CR29","doi-asserted-by":"publisher","first-page":"042","DOI":"10.7324\/JAPS.2016.600107","volume":"6","author":"MM Abdel-Moaty","year":"2016","unstructured":"Abdel-Moaty MM, Mohamed WS, Abdel-All SM, El-Hendawy HH. Prevalence and molecular epidemiology of extended spectrum \u00ce2-lactamase producing Escherichia coli from hospital and community settings in Egypt. J App Pharm Sci. 2016;6(1):042\u20137.","journal-title":"J App Pharm Sci"},{"issue":"1","key":"856_CR30","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1038\/s41598-020-59772-z","volume":"10","author":"NA Hassuna","year":"2020","unstructured":"Hassuna NA, Khairalla AS, Farahat EM, Hammad AM, Abdel-Fattah M. Molecular characterization of Extended-spectrum \u03b2 lactamase- producing E. coli recovered from community-acquired urinary tract infections in Upper Egypt. Sci Rep. 2020;10(1):2772 Published 2020 Feb 17.","journal-title":"Sci Rep"},{"issue":"3","key":"856_CR31","doi-asserted-by":"publisher","first-page":"522","DOI":"10.4269\/ajtmh.18-0396","volume":"100","author":"RY Shash","year":"2019","unstructured":"Shash RY, Elshimy AA, Soliman MY, Mosharafa AA. Molecular characterization of extended-Spectrum \u03b2-lactamase Enterobacteriaceae isolated from Egyptian patients with community- and hospital-acquired urinary tract infection. Am J Trop Med Hyg. 2019;100(3):522\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"856_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1469-0691.2007.01850.x","volume":"14","author":"R Canton","year":"2008","unstructured":"Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, et al. Prevalence and spread of extended-spectrum b-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect. 2008;14(1):144\u201353.","journal-title":"Clin Microbiol Infect"},{"key":"856_CR33","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.5897\/AJMR2016.8150","volume":"10","author":"M Salah","year":"2016","unstructured":"Salah M, Azab M, Halaby H, Hanora A. Mutations in \u03b2 lactamases detected in multidrug resistant gram-negative bacteria isolated from community acquired urinary tract infections in Assiut, Egypt. Afr J Microbiol Res. 2016;10:1938\u201343.","journal-title":"Afr J Microbiol Res"},{"issue":"14","key":"856_CR34","first-page":"1","volume":"16","author":"JN Kateregga","year":"2015","unstructured":"Kateregga JN, Kantume R, Atuhaire C, Lubowa MN, Ndukui JG. Phenotypic expression and prevalence of ESBL-producing Enterobacteriaceae in samples collected from patients in various wards of Mulago hospital. Uganda BMC Pharmacol Toxicol. 2015;16(14):1\u20136.","journal-title":"Uganda BMC Pharmacol Toxicol"},{"issue":"11","key":"856_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12879-016-1655-3","volume":"16","author":"AS Ouedraogo","year":"2016","unstructured":"Ouedraogo AS, Sanou M, Kissou A, Sanou S, Solar\u00e9 H, Kabor\u00e9 F, Poda A, Aberkane S, Bouzinbi N, Sano I, Nacro B, Sangar\u00e9 L, Carri\u00e8re C, Decr\u00e9 D, Ou\u00e9graogo R, Jean-Pierre H, Godreuil S. High prevalence of extended-spectrum \u00df-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso. BMC Infect Dis. 2016;16(11):326.","journal-title":"BMC Infect Dis"},{"issue":"15","key":"856_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13756-019-0488-4","volume":"8","author":"DS Teklu","year":"2019","unstructured":"Teklu DS, Negeri AA, Legese MH, Bedada TL, Woldemariam HK, Tullu KD. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrob Resist Infect Control. 2019;8(15):39 eCollection 2019. Published 2019 Feb 15.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"856_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.diagmicrobio.2012.05.024","volume":"74","author":"DJ Hoban","year":"2012","unstructured":"Hoban DJ, Lascols C, Nicolle LE, Badal R, Bouchillon S, Hackel M, Hawser S. Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase\u2013producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009\u20132010. Diagn Microbiol Infect Dis. 2012;74(1):62\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"856_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13756-019-0492-8","volume":"8","author":"KYL Chua","year":"2019","unstructured":"Chua KYL, Stewardson AJ. Individual and community predictors of urinary ceftriaxone-resistant Escherichia coli isolates, Victoria, Australia. Antimicrob Resist Infect Control. 2019;8:36. https:\/\/doi.org\/10.1186\/s13756-019-0492-8.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"23","key":"856_CR39","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2147\/IDR.S160720","volume":"11","author":"R Azargun","year":"2018","unstructured":"Azargun R, Sadeghi MR, Soroush Barhaghi MH, Samadi Kafil H, Yeganeh F, Ahangar Oskouee M, Ghotaslou R. The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections. Infect Drug Resist. 2018;11(23):1007\u201314.","journal-title":"Infect Drug Resist"},{"key":"856_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13756-018-0381-6","volume":"7","author":"NO Eltai","year":"2018","unstructured":"Eltai NO, Al Thani AA, Al-Ansari K, Deshmukh AS, Wehedy E, Al-Hadidi SH, Yassine HM. Molecular characterization of extended spectrum \u03b2 -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population. Antimicrob Resist Infect Control. 2018;7:90. https:\/\/doi.org\/10.1186\/s13756-018-0381-6 eCollection 2018. PMID: 30069306.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"856_CR41","doi-asserted-by":"publisher","first-page":"e13463","DOI":"10.1111\/ijcp.13463","volume":"74","author":"RMM Khairy","year":"2020","unstructured":"Khairy RMM, Mahmoud MS, Shady RR, Esmail MAM. Multidrug-resistant Klebsiella pneumoniae in hospital-acquired infections: concomitant analysis of antimicrobial resistant strains. Int J Clin Pract. 2020;74(4):e13463.","journal-title":"Int J Clin Pract"},{"key":"856_CR42","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.meegid.2011.06.001","volume":"11","author":"Y Chong","year":"2011","unstructured":"Chong Y, Ito Y, Kamimura T. Genetic evolution and clinical impact in extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect Gen Evol. 2011;11:1499\u2013504.","journal-title":"Infect Gen Evol"},{"key":"856_CR43","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1099\/jmm.0.059279-0","volume":"62","author":"Y Chong","year":"2013","unstructured":"Chong Y, Shimoda S, Yakushiji H, Ito Y, Miyamoto T, Kamimura T, et al. Community spread of extended-spectrum \u03b2-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a long-term study in Japan. J Med Microbiol. 2013;62:1038\u201343.","journal-title":"J Med Microbiol"},{"issue":"30","key":"856_CR44","first-page":"10","volume":"7","author":"N Maleki","year":"2018","unstructured":"Maleki N, Tahanasab Z, Mobasherizadeh S, Rezaei A, Faghri J. Prevalence of CTX-M and TEM \u03b2-lactamases in Klebsiella pneumoniae isolates from patients with urinary tract infection, Al-Zahra hospital, Isfahan, Iran. Adv Biomed Res. 2018;7(30):10.","journal-title":"Adv Biomed Res"},{"issue":"26","key":"856_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13756-019-0494-6","volume":"8","author":"KL Rensing","year":"2019","unstructured":"Rensing KL, Abdallah HM, Koek A, Elmowalid GA, Vandenbroucke-Grauls CMJE, Al Naiemi N, van Dijk K. Prevalence of plasmid-mediated AmpC in Enterobacteriaceae isolated from humans and from retail meat in Zagazig, Egypt. Antimicrob Resist Infect Control. 2019;8(26):45.","journal-title":"Antimicrob Resist Infect Control"},{"key":"856_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-0711-13-22","volume":"13","author":"SF Ahmed","year":"2014","unstructured":"Ahmed SF, Ali MM, Mohamed ZK, Moussa TA, Klena JD. Fecal carriage of extended-spectrum beta-lactamases and AmpC-producing Escherichia coli in a Libyan community. Ann Clin Microbiol Antimicrob. 2014;13:22.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"9","key":"856_CR47","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1099\/jmm.0.000504","volume":"66","author":"B Abdalhamid","year":"2017","unstructured":"Abdalhamid B, Albunayan S, Shaikh A, Elhadi N, Aljindan R. Prevalence study of plasmid-mediated AmpC \u03b2-lactamases in Enterobacteriaceae lacking inducible ampC from Saudi hospitals. J Med Microbiol. 2017;66(9):1286\u201390. https:\/\/doi.org\/10.1099\/jmm.0.000504 Epub 2017 Aug 18.","journal-title":"J Med Microbiol"},{"key":"856_CR48","doi-asserted-by":"publisher","first-page":"171548","DOI":"10.1155\/2014\/171548","volume":"2014","author":"MM Helmy","year":"2014","unstructured":"Helmy MM, Wasfi R. Phenotypic and molecular characterization of plasmid mediated AmpC \u03b2-lactamases among Escherichia coli, Klebsiella spp., and Proteus mirabilis isolated from urinary tract infections in Egyptian hospitals. Biomed Res Int. 2014;2014:171548. https:\/\/doi.org\/10.1155\/2014\/171548.","journal-title":"Biomed Res Int"},{"issue":"1","key":"856_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1128\/AAC.00828-15","volume":"60","author":"T Ch\u00e9rif","year":"2015","unstructured":"Ch\u00e9rif T, Saidani M, Decr\u00e9 D, Boutiba-Ben Boubaker I, Arlet G. Cooccurrence of Multiple AmpC \u03b2-Lactamases in Escherichia coli,Klebsiella pneumoniaee, and Proteus mirabilis in Tunisia. Antimicrob Agents Chemother. 2015;60(1):44\u201351.","journal-title":"Antimicrob Agents Chemother"},{"key":"856_CR50","doi-asserted-by":"crossref","unstructured":"Tamma PD, Shahara SL, Pana ZD, Amoah J, Fisher SL, Tekle T Doi Y, Simner PJ. Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States. Open Forum Infect Dis 2019 (11); 6(8). 2019 (11); 6(8).","DOI":"10.1093\/ofid\/ofz353"},{"key":"856_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1476-0711-9-19","volume":"9","author":"M Harajly","year":"2010","unstructured":"Harajly M, Khairallah M-T, Corkill JE, Araj GF, Matar GM. Frequency of conjugative transfer of plasmid-encoded ISEcp1 - blaCTX-M-15 and aac(6\u2032)-lb-cr genes in Enterobacteriaceae at a tertiary care center in Lebanon\u2014role of transferases. Ann Clin Microbiol Antimicrob. 2010;9:19.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"3","key":"856_CR52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1309\/LMDQQW246NYAHHAD","volume":"45","author":"SN Peerayeh","year":"2014","unstructured":"Peerayeh SN, Rostami E, Siadat SD, Derakhshan S. High rate of aminoglycoside resistance in CTX-M-15 producing Klebsiella pneumoniae isolates in Tehran. Iran Lab Med. 2014;45(3):231\u20137.","journal-title":"Iran Lab Med"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00856-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13756-020-00856-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00856-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T06:20:02Z","timestamp":1607581202000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-020-00856-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["856"],"URL":"https:\/\/doi.org\/10.1186\/s13756-020-00856-w","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"9 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the local ethics committee, Faculty of Medicine, Minia University. Written informed consents were obtained from all patients for the use of their samples.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}